Literature DB >> 26262505

Logistical Factors Influencing Cold Ischemia Times in Deceased Donor Kidney Transplants.

Sussie Shrestha1, Lisa Bradbury, Matthew Boal, James P Blackmur, Christopher J E Watson, Craig J Taylor, John L R Forsythe, Rachel Johnson, Lorna P Marson.   

Abstract

BACKGROUND: Prolonged cold ischemia time (CIT) is associated with a significant risk of short- and long-term graft failure in deceased donor kidney transplants across the world. The aim of this prospective longitudinal study was to determine the importance of logistical factors on CIT.
METHOD: Data on 1763 transplants were collected prospectively over 14 months from personnel in 16 transplant centers, 19 histocompatibility and immunogenetics laboratories, transport providers, and National Health Service Blood and Transplant.
RESULTS: The overall mean CIT was 13.8 hours, with significant center variation (P < 0.0001). Factors that significantly reduced CIT were donation after circulatory death (P = 0.03), shorter transport time (P = 0.0002), use of virtual crossmatch (XM) (P < 0.0001), and use of donor blood for pretransplant XM (P < 0.0001). The CIT for transplants that went ahead with a virtual XM was 3 hours shorter than those requiring a pretransplant XM (P < 0.0001). There was a mean delay of 3 hours in starting transplants despite organ, recipient, and pretransplant XM result being ready, suggesting that theater access contributes significantly to increased CIT. DISCUSSION: This study identifies logistical factors relating to donor, transport, crossmatching, recipient, and theater that impact significantly on CIT in deceased donor renal transplantation, some of which are modifiable; attention should be focussed on addressing all of these.

Entities:  

Mesh:

Year:  2016        PMID: 26262505     DOI: 10.1097/TP.0000000000000844

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Donor Age, Cold Ischemia Time, and Delayed Graft Function.

Authors:  Ilkka Helanterä; Hassan N Ibrahim; Marko Lempinen; Patrik Finne
Journal:  Clin J Am Soc Nephrol       Date:  2020-05-13       Impact factor: 8.237

2.  Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants.

Authors:  Eric K Chow; Sandra DiBrito; Xun Luo; Corey E Wickliffe; Allan B Massie; Jayme E Locke; Sommer E Gentry; Jacqueline Garonzik-Wang; Dorry L Segev
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

3.  Virtual Crossmatching in Kidney Transplantation, Shiraz Experience in Development of a Web-Based Program.

Authors:  N Jamshidian Tehrani; B Geramizadeh; S A Malekhosseini; S Nikeghbalian; A Bahador; S Gholami; G A Raees Jalali; J Roozbeh; M H Anbardar; N Soleimani; N Rasaei; S Mohammadzadeh
Journal:  Int J Organ Transplant Med       Date:  2021

Review 4.  BSHI/BTS guidance on crossmatching before deceased donor kidney transplantation.

Authors:  S Peacock; D Briggs; M Barnardo; R Battle; P Brookes; C Callaghan; B Clark; C Collins; S Day; N Diaz Burlinson; P Dunn; R Fernando; S Fuggle; A Harmer; D Kallon; D Keegan; T Key; E Lawson; S Lloyd; J Martin; J McCaughan; D Middleton; F Partheniou; A Poles; T Rees; D Sage; E Santos-Nunez; O Shaw; M Willicombe; J Worthington
Journal:  Int J Immunogenet       Date:  2021-09-23       Impact factor: 2.385

5.  Trends and impact on cold ischemia time and clinical outcomes using virtual crossmatch for deceased donor kidney transplantation in the United States.

Authors:  Chethan M Puttarajappa; Dana Jorgensen; Jonathan G Yabes; Kwonho Jeong; Adriana Zeevi; John Lunz; Amit D Tevar; Michele Molinari; Sumit Mohan; Sundaram Hariharan
Journal:  Kidney Int       Date:  2021-04-30       Impact factor: 18.998

Review 6.  Organ donation and transplantation: a multi-stakeholder call to action.

Authors:  Raymond Vanholder; Beatriz Domínguez-Gil; Mirela Busic; Helena Cortez-Pinto; Jonathan C Craig; Kitty J Jager; Beatriz Mahillo; Vianda S Stel; Maria O Valentin; Carmine Zoccali; Gabriel C Oniscu
Journal:  Nat Rev Nephrol       Date:  2021-05-05       Impact factor: 28.314

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.